CLARESSA DONLEY: Open Payments
NPI 1376061663 · DECATUR, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,432 in 90 payments from 41 companies in 2025. Trend: 2023 $833 · 2024 $708 · 2025 $2,432
Food & beverage: $2,274Education: $158
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $178 |
| Janssen Biotech, Inc. | 4 | $156 |
| Genmab U.S., Inc. | 2 | $136 |
| Merck Sharp & Dohme LLC | 5 | $121 |
| Regeneron Healthcare Solutions, Inc. | 3 | $113 |
| E.R. Squibb & Sons, L.L.C. | 5 | $113 |
| SHIELD THERAPEUTICS INC | 3 | $107 |
| SANOFI US SERVICES INC. | 1 | $104 |
| PFIZER INC. | 4 | $97 |
| AstraZeneca Pharmaceuticals LP | 4 | $90 |
Products named: DARZALEX, Epkinly, KEYTRUDA, LIBTAYO, ACCRUFER, KISQALI, Orserdu, PROVENGE.
Industry payments across TX — which companies pay providers there.
